Rocket Pharmaceuticals Inc (RCKT) Insider Trading
- $57,917,799.30
- $46,796,606.21
- Aug. 27, 2025
- John Militello
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 27, 2025 | Director | 10,000 | $3.41 | Buy | $34,100.00 | |
Aug. 19, 2025 | Insider | 805 | $3.00 | Sell | $2,415.00 | |
Aug. 19, 2025 | General Counsel | 588 | $3.00 | Sell | $1,764.00 | |
Aug. 19, 2025 | Insider | 361 | $3.00 | Sell | $1,083.00 | |
Aug. 18, 2025 | Insider | 1,680 | $3.06 | Sell | $5,140.80 | |
Aug. 18, 2025 | Insider | 699 | $3.06 | Sell | $2,138.94 | |
Aug. 18, 2025 | General Counsel | 1,004 | $3.06 | Sell | $3,072.24 | |
Aug. 14, 2025 | General Counsel | 12,109 | $3.02 | Sell | $36,569.18 | |
Aug. 14, 2025 | Insider | 11,161 | $3.02 | Sell | $33,706.22 | |
Aug. 14, 2025 | Insider | 7,043 | $3.02 | Sell | $21,269.86 | |
July 3, 2025 | CFO | 1,477 | $2.88 | Sell | $4,253.76 | |
April 22, 2025 | Insider | 718 | $7.16 | Sell | $5,140.88 | |
April 10, 2025 | CEO | 20,000 | $5.08 | Buy | $101,600.00 | |
April 9, 2025 | Insider | 21,099 | $4.70 | Buy | $99,165.30 | |
April 4, 2025 | CFO | 7,489 | $5.29 | Sell | $39,616.81 | |
Jan. 23, 2025 | Insider | 896 | $10.38 | Sell | $9,300.48 | |
Nov. 21, 2024 | CEO | 11,091 | $13.05 | Sell | $144,737.55 | |
Nov. 21, 2024 | Insider | 1,224 | $13.05 | Sell | $15,973.20 | |
Nov. 21, 2024 | General Counsel | 1,175 | $13.05 | Sell | $15,333.75 | |
July 22, 2024 | Insider | 812 | $23.02 | Sell | $18,692.24 | |
July 8, 2024 | Insider | 3,026 | $20.39 | Sell | $61,700.14 | |
May 16, 2024 | Insider | 1,079 | $23.35 | Sell | $25,194.65 | |
May 16, 2024 | General Counsel | 1,048 | $23.35 | Sell | $24,470.80 | |
May 16, 2024 | CEO | 9,790 | $23.35 | Sell | $228,596.50 | |
April 22, 2024 | Insider | 833 | $22.87 | Sell | $19,050.71 | |
April 15, 2024 | Director | 10,000 | $24.05 | Sell | $240,500.00 | |
April 12, 2024 | Director | 70,000 | $24.36 | Sell | $1,705,200.00 | |
April 8, 2024 | Insider | 12,532 | $24.64 | Sell | $308,788.48 | |
March 21, 2024 | Insider | 2,490 | $28.10 | Sell | $69,969.00 | |
March 21, 2024 | Director | 274,000 | $28.43 | Sell | $7,789,820.00 | |
Feb. 29, 2024 | General Counsel | 4,100 | $29.33 | Sell | $120,253.00 | |
Feb. 29, 2024 | Insider | 10,000 | $29.84 | Sell | $298,400.00 | |
Feb. 16, 2024 | General Counsel | 3,576 | $29.84 | Sell | $106,707.84 | |
Feb. 16, 2024 | Insider | 7,132 | $29.84 | Sell | $212,818.88 | |
Feb. 16, 2024 | CEO | 20,272 | $29.84 | Sell | $604,916.48 | |
Jan. 22, 2024 | Insider | 638 | $27.20 | Sell | $17,353.60 | |
Nov. 15, 2023 | Director | 20,000 | $22.53 | Sell | $450,600.00 | |
Oct. 20, 2023 | Insider | 564 | $17.06 | Sell | $9,621.84 | |
Sept. 28, 2023 | Director | 10,312 | $21.03 | Sell | $216,861.36 | |
Aug. 17, 2023 | CEO | 4,767 | $15.47 | Sell | $73,745.49 | |
Aug. 17, 2023 | Insider | 1,534 | $15.47 | Sell | $23,730.98 | |
July 20, 2023 | Insider | 573 | $19.03 | Sell | $10,904.19 | |
April 21, 2023 | Insider | 2,342 | $18.65 | Sell | $43,678.30 | |
Feb. 17, 2023 | Insider | 3,557 | $19.06 | Sell | $67,796.42 | |
Feb. 17, 2023 | CEO | 12,194 | $19.06 | Sell | $232,417.64 | |
Oct. 6, 2022 | Director | 1,355,932 | $14.75 | Buy | $19,999,997.00 | |
March 30, 2022 | Insider | 45,000 | $16.41 | Sell | $738,450.00 | |
Feb. 7, 2022 | CEO | 22,000 | $17.34 | Buy | $381,480.00 | |
May 11, 2021 | Director | 725,000 | $40.03 | Sell | $29,021,750.00 | |
Dec. 28, 2020 | COO | 16,761 | $56.72 | Sell | $950,683.92 |
Insiders are both buying and selling Rocket Pharmaceuticals Inc stock.
The insider traders at Rocket Pharmaceuticals Inc are: John Militello, Gaurav Shah, Martin Wilson, Kinnari Patel, Rtw Investments, Lp, Jonathan David Schwartz, David P Southwell, Gotham Makker, Mark Andrew White, Aaron Ondrey, David P. Southwell, J Martin Carroll, Argeris N Karabelas, Naveen Yalamanchi, Park Bioventures Lp Devon, and Elisabeth Bjork
The most active insider trader at Rocket Pharmaceuticals Inc is John Militello with 15 trades.
Rtw Investments, Lp has sold the most Rocket Pharmaceuticals Inc stock with a total value of $58,043,500.00.
Rtw Investments, Lp has bought the most Rocket Pharmaceuticals Inc stock with a total value of $68,503,651.50.
The most recent insider trade for Rocket Pharmaceuticals Inc was on Aug. 27, 2025.
The single biggest insider buy for Rocket Pharmaceuticals Inc was from Rtw Investments, Lp with a total value of $19,999,997.00 on Oct. 6, 2022.
The single biggest insider sell for Rocket Pharmaceuticals Inc was from Rtw Investments, Lp with a total value of $29,021,750.00 on May 11, 2021.